Mehrad Adibi

The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Phase 1b Trial Evaluating Tolerability and Activity of Targeted Fibroblast Growth Factor Receptor Inhibition in Localized Upper Tract Urothelial Carcinoma”.

Phase 1b Trial Evaluating Tolerability and Activity of Targeted Fibroblast Growth Factor Receptor Inhibition in Localized Upper Tract Urothelial Carcinoma

The Journal of Urology(2024)10.1097/ju.0000000000003928

N/A

0.411DataRank · unranked

8 citations

Mehrad Adibi, Amishi Y. Shah, Omar Alhalabi, Paul G. Corn, Charles C. Guo +8 more

Neoadjuvant apalutamide (APA) plus leuprolide (LHRHa) with or without abiraterone (AA) in localized high-risk prostate cancer (LHRPC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.5504

N/A

0DataRank · unranked

18 citations

Myrto Boukovala, Nicholas Spetsieris, Sijin Wen, Anh Hoang, Justin A. Weldon +15 more